Authorities in OhioAnd the New YorkAnd the New JerseyAnd the ConnecticutAnd the MassachusettsAnd the Maryland, Nebraska, GeorgiaAnd the IndianaAnd Texas Virginia He said on Tuesday that they would follow Call on federal health agencies to stop administering Johnson & Johnson vaccine After six women in the United States developed a rare disorder involving blood clots within about two weeks of being vaccinated.

CVS, the nation’s largest retail pharmacy chain, said it would immediately stop using Johnson & Johnson vaccines and was sending an email to customers whose appointments would be canceled. A spokesperson said CVS will reschedule the appointments “as soon as possible”.

Gov. Mike DeWine Ohio The state’s chief health official said they are advising all state vaccine providers to temporarily stop using the single-dose vaccine. New York Health Commissioner Dr. Howard Zucker said the state will stop using the Johnson & Johnson vaccine, while the Food and Drug Administration and the Centers for Disease Control and Prevention are assessing safety risks.

Connecticut health officials said they are He asked the vaccine providers to delay the scheduled appointments And give an alternate option if they have the offer.

The Centers for Disease Control and Prevention’s external advisory committee scheduled an emergency meeting for Wednesday.

Jeff Zentes, the White House coordinator for the Covid virus, said on Tuesday that the stoppage will not have a significant impact on the vaccination campaign in the country, which has accelerated in recent weeks as a rise in new cases of the new virus threatens a fourth possible increase. Many countries have already been conquered Eligibility for vaccination For all adults and others plan by next week.

“During the past few weeks, we have provided more than 25 million doses of Pfizer and Moderna every week, and in fact this week we will provide 28 million doses of these vaccines. This offer is more than enough to continue the current pace of vaccinations of 3 million shots.” in a day.

Although reaction to the Johnson & Johnson injection is rare, any questions about the safety of the shots can reinforce hesitation about the vaccine.

Nearly seven million people in the United States have received shots from Johnson & Johnson to date, and nearly nine million more doses have been shipped to the states, according to data from the Centers for Disease Control and Prevention. The six women suffering from blood clots were between 18 and 48 years old. One woman died and another woman was hospitalized in Nebraska in critical condition.

“At the moment, it appears that these adverse events are extremely rare,” said Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biological Assessment and Research, and Dr. Anne Schuchat, lead deputy director of the CDC, said. Joint statement on Tuesday. “People who have received the J&J vaccine and who experience severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their healthcare provider.”

Like many states, it is new York was already bracing for a major post-federation drop in Johnson & Johnson vaccine supplies Officials said supplies will be limited due to a production problem at the Baltimore manufacturing plant. On Friday, Governor Andrew M. Cuomo said New York expects to receive 34,900 injections of Johnson & Johnson, an 88 percent decrease from the previous week.

Dr. Zucker, New York’s health commissioner, said the state will honor appointments made at state-run mass vaccination sites for the Johnson & Johnson vaccine by giving people the Pfizer-BioNTech vaccine instead. This vaccine required two doses, and it was not immediately clear how the country would cope with the added pressure on its supplies.

New York City Mayor Bill de Blasio said the city will work to reschedule appointments at vaccination sites the city runs, giving these people the Pfizer or Moderna vaccines instead.

“This morning every site has been told to stop giving J&J footage,” he said at a press conference.

Mr Cuomo received the Johnson & Johnson vaccine at a public appearance last month in Harlem, which he framed as an effort to boost confidence in it. The vaccine efficacy rate To treat vaccine frequency.

Regulators in Europe and elsewhere are concerned about a similar problem with another coronavirus vaccine, developed by AstraZeneca And Oxford University researchers. This vaccine is not approved for emergency use in the United States.